Shopping Cart 0
Cart Subtotal
USD 0

Europe Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 2600

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 3500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 4400

Details

Europe biosurgery market accounted for USD 3,610.6 million in 2020 and will grow by 6.2% annually over 2020-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.

Highlighted with 34 tables and 50 figures, this 104-page report Europe Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity is based on a comprehensive research of the entire Europe biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country.

 

Based on Product, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2017-2027 included in each section.

Hemostatic Agents

Bone-graft Substitutes

o Synthetic Graft Extender

o Demineralized Bone Matrix

o Bone Morphogenetic Proteins

o Cell-Based Matrices

Surgical Sealants and Adhesives

o Natural Surgical Sealing Agents

o Synthetic Surgical Sealing Agents

Soft-tissue Attachments

o Natural & Biological Mesh/Patch

o Synthetic Mesh/Patch

Adhesion Barriers

o Natural Adhesion Barriers

o Synthetic Adhesion Barriers

Staple Line Reinforcement

 

Based on Source Type, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2017-2027 included in each section.

Natural/Biological Products

Synthetic Products

 

Based on Application, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2017-2027 included in each section.

Orthopedic Surgery

General Surgery

Neurological Surgery

Cardiovascular Surgery

Gynecological Surgery

Other Applications

 

Geographically, the following national/local markets are fully investigated:

Germany

UK

France

Spain

Italy

Russia

Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included.

 

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

B. Braun Melsungen AG

Baxter International, Inc.

Becton, Dickinson and Company (C.R. Bard)

Betatech Medical

CryoLife Inc.

CSL Limited

Hemostasis LLC

Integra Lifesciences Holdings Corporation

Johnson & Johnson

Medtronic PLC

Pfizer, Inc.

Sanofi S.A.

Stryker Corporation

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Table Of Content

Scope

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 13

1.2.6 Market Size/Share Estimation 14

1.2.7 Research Limitations 15

1.3 Executive Summary 16

2 Market Overview and Dynamics 18

2.1 Market Size and Forecast 18

2.1.1 Impact of COVID-19 on World Economy 19

2.1.2 Impact of COVID-19 on the Market 21

2.2 Major Growth Drivers 23

2.3 Market Restraints and Challenges 27

2.4 Emerging Opportunities and Market Trends 30

2.5 Porter's Fiver Forces Analysis 34

3 Segmentation of Europe Market by Product 38

3.1 Market Overview by Product 38

3.2 Hemostatic Agents 40

3.3 Bone-graft Substitutes 41

3.2.1 Synthetic Graft Extender 42

3.2.2 Demineralized Bone Matrix 43

3.2.3 Bone Morphogenetic Proteins 44

3.2.4 Cell-Based Matrices 45

3.4 Surgical Sealants and Adhesives 46

3.4.1 Natural Surgical Sealing Agents 47

3.4.2 Synthetic Surgical Sealing Agents 48

3.5 Soft-tissue Attachments 49

3.5.1 Natural & Biological Mesh/Patch 50

3.5.2 Synthetic Mesh/Patch 51

3.6 Adhesion Barriers 52

3.6.1 Natural Adhesion Barriers 53

3.6.2 Synthetic Adhesion Barriers 54

3.7 Staple Line Reinforcement 55

4 Segmentation of Europe Market by Source Type 56

4.1 Market Overview by Source Type 56

4.2 Natural/Biological Products 58

4.3 Synthetic Products 59

5 Segmentation of Europe Market by Application 61

5.1 Market Overview by Application 61

5.2 Orthopedic Surgery 63

5.3 General Surgery 64

5.4 Neurological Surgery 65

5.5 Cardiovascular Surgery 66

5.6 Gynecological Surgery 67

5.7 Other Applications 68

6 European Market 2020-2027 by Country 69

6.1 Overview of European Market 69

6.2 UK 72

6.3 France 74

6.4 Germany 76

6.5 Spain 78

6.6 Italy 80

6.7 Russia 82

6.8 Rest of European Market 84

7 Competitive Landscape 86

7.1 Overview of Key Vendors 86

7.2 New Product Launch, Partnership, Investment, and M&A 89

7.3 Company Profiles 90

B. Braun Melsungen AG 90

Baxter International, Inc. 92

Becton, Dickinson and Company (C.R. Bard) 93

Betatech Medical 94

CryoLife Inc. 95

CSL Limited 96

Hemostasis LLC 97

Integra Lifesciences Holdings Corporation 98

Johnson & Johnson 99

Medtronic PLC 100

Pfizer, Inc. 101

Sanofi S.A. 102

Stryker Corporation 103

RELATED REPORTS 104


List Of Figure

Figure 1. Research Method Flow Chart 11

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14

Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 16

Figure 4. Europe Biosurgery Market, 2017-2027, USD mn 18

Figure 5. Impact of COVID-19 on Business 21

Figure 6. Primary Drivers and Impact Factors of Europe Biosurgery Market 23

Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26

Figure 8. Primary Restraints and Impact Factors of Europe Biosurgery Market 27

Figure 9. Investment Opportunity Analysis 31

Figure 10. Porter's Fiver Forces Analysis of Europe Biosurgery Market 34

Figure 11. Breakdown of Europe Biosurgery Market by Product, 2020-2027, % of Revenue 38

Figure 12. Contribution to Europe 2021-2027 Cumulative Revenue by Product, Value (USD mn) and Share (%) 39

Figure 13. Europe Biosurgery Market: Hemostatic Agents, 2017-2027, USD mn 40

Figure 14. Europe Biosurgery Market: Bone-graft Substitutes, 2017-2027, USD mn 41

Figure 15. Europe Biosurgery Market: Synthetic Graft Extender, 2017-2027, USD mn 42

Figure 16. Europe Biosurgery Market: Demineralized Bone Matrix, 2017-2027, USD mn 43

Figure 17. Europe Biosurgery Market: Bone Morphogenetic Proteins, 2017-2027, USD mn 44

Figure 18. Europe Biosurgery Market: Cell-Based Matrices, 2017-2027, USD mn 45

Figure 19. Europe Biosurgery Market: Surgical Sealants and Adhesives, 2017-2027, USD mn 46

Figure 20. Europe Biosurgery Market: Natural Surgical Sealing Agents, 2017-2027, USD mn 47

Figure 21. Europe Biosurgery Market: Synthetic Surgical Sealing Agents, 2017-2027, USD mn 48

Figure 22. Europe Biosurgery Market: Soft-tissue Attachments, 2017-2027, USD mn 49

Figure 23. Europe Biosurgery Market: Natural & Biological Mesh/Patch, 2017-2027, USD mn 50

Figure 24. Europe Biosurgery Market: Synthetic Mesh/Patch, 2017-2027, USD mn 51

Figure 25. Europe Biosurgery Market: Adhesion Barriers, 2017-2027, USD mn 52

Figure 26. Europe Biosurgery Market: Natural Adhesion Barriers, 2017-2027, USD mn 53

Figure 27. Europe Biosurgery Market: Synthetic Adhesion Barriers, 2017-2027, USD mn 54

Figure 28. Europe Biosurgery Market: Staple Line Reinforcement, 2017-2027, USD mn 55

Figure 29. Breakdown of Europe Biosurgery Market by Source Type, 2020-2027, % of Revenue 56

Figure 30. Contribution to Europe 2021-2027 Cumulative Revenue by Source Type, Value (USD mn) and Share (%) 57

Figure 31. Europe Biosurgery Market: Natural/Biological Products, 2017-2027, USD mn 58

Figure 32. Europe Biosurgery Market: Synthetic Products, 2017-2027, USD mn 59

Figure 33. Breakdown of Europe Biosurgery Market by Application, 2020-2027, % of Revenue 62

Figure 34. Contribution to Europe 2021-2027 Cumulative Revenue by Application, Value (USD mn) and Share (%) 62

Figure 35. Europe Biosurgery Market: Orthopedic Surgery, 2017-2027, USD mn 63

Figure 36. Europe Biosurgery Market: General Surgery, 2017-2027, USD mn 64

Figure 37. Europe Biosurgery Market: Neurological Surgery, 2017-2027, USD mn 65

Figure 38. Europe Biosurgery Market: Cardiovascular Surgery, 2017-2027, USD mn 66

Figure 39. Europe Biosurgery Market: Gynecological Surgery, 2017-2027, USD mn 67

Figure 40. Europe Biosurgery Market: Other Applications, 2017-2027, USD mn 68

Figure 41. Breakdown of European Biosurgery Market by Country, 2020 and 2027, % of Revenue 70

Figure 42. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 71

Figure 43. Biosurgery Market in UK, 2017-2027, USD mn 72

Figure 44. Biosurgery Market in France, 2017-2027, USD mn 74

Figure 45. Biosurgery Market in Germany, 2017-2027, USD mn 76

Figure 46. Biosurgery Market in Spain, 2017-2027, USD mn 78

Figure 47. Biosurgery Market in Italy, 2017-2027, USD mn 80

Figure 48. Biosurgery Market in Russia, 2017-2027, USD mn 82

Figure 49. Biosurgery Market in Rest of Europe, 2017-2027, USD mn 84

Figure 50. Growth Stage of Europe Biosurgery Industry over the Forecast Period 86


List Of Table

Table 1. Snapshot of Europe Biosurgery Market in Balanced Perspective, 2020-2027 17

Table 2. Growth Rate of World GDP, 2020-2022 20

Table 3. Main Product Trends and Market Opportunities in Europe Biosurgery Market 30

Table 4. Europe Biosurgery Market by Product, 2017-2027, USD mn 38

Table 5. Europe Biosurgery Market: Bone-Graft Substitutes by Type, 2017-2027, USD mn 41

Table 6. Europe Biosurgery Market: Surgical Sealants and Adhesives by Type, 2017-2027, USD mn 46

Table 7. Europe Biosurgery Market: Soft-tissue Attachments by Type, 2017-2027, USD mn 49

Table 8. Europe Biosurgery Market: Adhesion Barriers by Type, 2017-2027, USD mn 52

Table 9. Europe Biosurgery Market by Source Type, 2017-2027, USD mn 56

Table 10. Europe Biosurgery Market by Application, 2017-2027, USD mn 61

Table 11. Europe Biosurgery Market by Country, 2017-2027, USD mn 71

Table 12. UK Biosurgery Market by Product, 2017-2027, USD mn 73

Table 13. UK Biosurgery Market by Source Type, 2017-2027, USD mn 73

Table 14. UK Biosurgery Market by Application, 2017-2027, USD mn 73

Table 15. France Biosurgery Market by Product, 2017-2027, USD mn 75

Table 16. France Biosurgery Market by Source Type, 2017-2027, USD mn 75

Table 17. France Biosurgery Market by Application, 2017-2027, USD mn 75

Table 18. Germany Biosurgery Market by Product, 2017-2027, USD mn 77

Table 19. Germany Biosurgery Market by Source Type, 2017-2027, USD mn 77

Table 20. Germany Biosurgery Market by Application, 2017-2027, USD mn 77

Table 21. Spain Biosurgery Market by Product, 2017-2027, USD mn 79

Table 22. Spain Biosurgery Market by Source Type, 2017-2027, USD mn 79

Table 23. Spain Biosurgery Market by Application, 2017-2027, USD mn 79

Table 24. Italy Biosurgery Market by Product, 2017-2027, USD mn 81

Table 25. Italy Biosurgery Market by Source Type, 2017-2027, USD mn 81

Table 26. Italy Biosurgery Market by Application, 2017-2027, USD mn 81

Table 27. Russia Biosurgery Market by Product, 2017-2027, USD mn 83

Table 28. Russia Biosurgery Market by Source Type, 2017-2027, USD mn 83

Table 29. Russia Biosurgery Market by Application, 2017-2027, USD mn 83

Table 30. Biosurgery Market in Rest of Europe by Country, 2017-2027, USD mn 85

Table 31. B. Braun Melsungen AG: Company Snapshot 90

Table 32. B. Braun Melsungen AG: Business Segmentation 90

Table 33. B. Braun Melsungen AG: Product Portfolio 91

Table 34. B. Braun Melsungen AG: Revenue, 2017-2019, USD mn 91

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

B. Braun Melsungen AG

Baxter International, Inc.

Becton, Dickinson and Company (C.R. Bard)

Betatech Medical

CryoLife Inc.

CSL Limited

Hemostasis LLC

Integra Lifesciences Holdings Corporation

Johnson & Johnson

Medtronic PLC

Pfizer, Inc.

Sanofi S.A.

Stryker Corporation

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Company Profile

Company Profile Title

Europe biosurgery market accounted for USD 3,610.6 million in 2020 and will grow by 6.2% annually over 2020-2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population.

Highlighted with 34 tables and 50 figures, this 104-page report Europe Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity is based on a comprehensive research of the entire Europe biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country.

 

Based on Product, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2017-2027 included in each section.

Hemostatic Agents

Bone-graft Substitutes

o Synthetic Graft Extender

o Demineralized Bone Matrix

o Bone Morphogenetic Proteins

o Cell-Based Matrices

Surgical Sealants and Adhesives

o Natural Surgical Sealing Agents

o Synthetic Surgical Sealing Agents

Soft-tissue Attachments

o Natural & Biological Mesh/Patch

o Synthetic Mesh/Patch

Adhesion Barriers

o Natural Adhesion Barriers

o Synthetic Adhesion Barriers

Staple Line Reinforcement

 

Based on Source Type, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2017-2027 included in each section.

Natural/Biological Products

Synthetic Products

 

Based on Application, the Europe market is segmented into the following sub-markets with annual revenue (USD mn) for 2017-2027 included in each section.

Orthopedic Surgery

General Surgery

Neurological Surgery

Cardiovascular Surgery

Gynecological Surgery

Other Applications

 

Geographically, the following national/local markets are fully investigated:

Germany

UK

France

Spain

Italy

Russia

Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included.

 

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

B. Braun Melsungen AG

Baxter International, Inc.

Becton, Dickinson and Company (C.R. Bard)

Betatech Medical

CryoLife Inc.

CSL Limited

Hemostasis LLC

Integra Lifesciences Holdings Corporation

Johnson & Johnson

Medtronic PLC

Pfizer, Inc.

Sanofi S.A.

Stryker Corporation

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

READ MORE

Scope

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 8

1.2 Research Methodology 11

1.2.1 Overview of Market Research Methodology 11

1.2.2 Market Assumption 12

1.2.3 Secondary Data 12

1.2.4 Primary Data 12

1.2.5 Data Filtration and Model Design 13

1.2.6 Market Size/Share Estimation 14

1.2.7 Research Limitations 15

1.3 Executive Summary 16

2 Market Overview and Dynamics 18

2.1 Market Size and Forecast 18

2.1.1 Impact of COVID-19 on World Economy 19

2.1.2 Impact of COVID-19 on the Market 21

2.2 Major Growth Drivers 23

2.3 Market Restraints and Challenges 27

2.4 Emerging Opportunities and Market Trends 30

2.5 Porter's Fiver Forces Analysis 34

3 Segmentation of Europe Market by Product 38

3.1 Market Overview by Product 38

3.2 Hemostatic Agents 40

3.3 Bone-graft Substitutes 41

3.2.1 Synthetic Graft Extender 42

3.2.2 Demineralized Bone Matrix 43

3.2.3 Bone Morphogenetic Proteins 44

3.2.4 Cell-Based Matrices 45

3.4 Surgical Sealants and Adhesives 46

3.4.1 Natural Surgical Sealing Agents 47

3.4.2 Synthetic Surgical Sealing Agents 48

3.5 Soft-tissue Attachments 49

3.5.1 Natural & Biological Mesh/Patch 50

3.5.2 Synthetic Mesh/Patch 51

3.6 Adhesion Barriers 52

3.6.1 Natural Adhesion Barriers 53

3.6.2 Synthetic Adhesion Barriers 54

3.7 Staple Line Reinforcement 55

4 Segmentation of Europe Market by Source Type 56

4.1 Market Overview by Source Type 56

4.2 Natural/Biological Products 58

4.3 Synthetic Products 59

5 Segmentation of Europe Market by Application 61

5.1 Market Overview by Application 61

5.2 Orthopedic Surgery 63

5.3 General Surgery 64

5.4 Neurological Surgery 65

5.5 Cardiovascular Surgery 66

5.6 Gynecological Surgery 67

5.7 Other Applications 68

6 European Market 2020-2027 by Country 69

6.1 Overview of European Market 69

6.2 UK 72

6.3 France 74

6.4 Germany 76

6.5 Spain 78

6.6 Italy 80

6.7 Russia 82

6.8 Rest of European Market 84

7 Competitive Landscape 86

7.1 Overview of Key Vendors 86

7.2 New Product Launch, Partnership, Investment, and M&A 89

7.3 Company Profiles 90

B. Braun Melsungen AG 90

Baxter International, Inc. 92

Becton, Dickinson and Company (C.R. Bard) 93

Betatech Medical 94

CryoLife Inc. 95

CSL Limited 96

Hemostasis LLC 97

Integra Lifesciences Holdings Corporation 98

Johnson & Johnson 99

Medtronic PLC 100

Pfizer, Inc. 101

Sanofi S.A. 102

Stryker Corporation 103

RELATED REPORTS 104


List Of Figure

Figure 1. Research Method Flow Chart 11

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14

Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 16

Figure 4. Europe Biosurgery Market, 2017-2027, USD mn 18

Figure 5. Impact of COVID-19 on Business 21

Figure 6. Primary Drivers and Impact Factors of Europe Biosurgery Market 23

Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26

Figure 8. Primary Restraints and Impact Factors of Europe Biosurgery Market 27

Figure 9. Investment Opportunity Analysis 31

Figure 10. Porter's Fiver Forces Analysis of Europe Biosurgery Market 34

Figure 11. Breakdown of Europe Biosurgery Market by Product, 2020-2027, % of Revenue 38

Figure 12. Contribution to Europe 2021-2027 Cumulative Revenue by Product, Value (USD mn) and Share (%) 39

Figure 13. Europe Biosurgery Market: Hemostatic Agents, 2017-2027, USD mn 40

Figure 14. Europe Biosurgery Market: Bone-graft Substitutes, 2017-2027, USD mn 41

Figure 15. Europe Biosurgery Market: Synthetic Graft Extender, 2017-2027, USD mn 42

Figure 16. Europe Biosurgery Market: Demineralized Bone Matrix, 2017-2027, USD mn 43

Figure 17. Europe Biosurgery Market: Bone Morphogenetic Proteins, 2017-2027, USD mn 44

Figure 18. Europe Biosurgery Market: Cell-Based Matrices, 2017-2027, USD mn 45

Figure 19. Europe Biosurgery Market: Surgical Sealants and Adhesives, 2017-2027, USD mn 46

Figure 20. Europe Biosurgery Market: Natural Surgical Sealing Agents, 2017-2027, USD mn 47

Figure 21. Europe Biosurgery Market: Synthetic Surgical Sealing Agents, 2017-2027, USD mn 48

Figure 22. Europe Biosurgery Market: Soft-tissue Attachments, 2017-2027, USD mn 49

Figure 23. Europe Biosurgery Market: Natural & Biological Mesh/Patch, 2017-2027, USD mn 50

Figure 24. Europe Biosurgery Market: Synthetic Mesh/Patch, 2017-2027, USD mn 51

Figure 25. Europe Biosurgery Market: Adhesion Barriers, 2017-2027, USD mn 52

Figure 26. Europe Biosurgery Market: Natural Adhesion Barriers, 2017-2027, USD mn 53

Figure 27. Europe Biosurgery Market: Synthetic Adhesion Barriers, 2017-2027, USD mn 54

Figure 28. Europe Biosurgery Market: Staple Line Reinforcement, 2017-2027, USD mn 55

Figure 29. Breakdown of Europe Biosurgery Market by Source Type, 2020-2027, % of Revenue 56

Figure 30. Contribution to Europe 2021-2027 Cumulative Revenue by Source Type, Value (USD mn) and Share (%) 57

Figure 31. Europe Biosurgery Market: Natural/Biological Products, 2017-2027, USD mn 58

Figure 32. Europe Biosurgery Market: Synthetic Products, 2017-2027, USD mn 59

Figure 33. Breakdown of Europe Biosurgery Market by Application, 2020-2027, % of Revenue 62

Figure 34. Contribution to Europe 2021-2027 Cumulative Revenue by Application, Value (USD mn) and Share (%) 62

Figure 35. Europe Biosurgery Market: Orthopedic Surgery, 2017-2027, USD mn 63

Figure 36. Europe Biosurgery Market: General Surgery, 2017-2027, USD mn 64

Figure 37. Europe Biosurgery Market: Neurological Surgery, 2017-2027, USD mn 65

Figure 38. Europe Biosurgery Market: Cardiovascular Surgery, 2017-2027, USD mn 66

Figure 39. Europe Biosurgery Market: Gynecological Surgery, 2017-2027, USD mn 67

Figure 40. Europe Biosurgery Market: Other Applications, 2017-2027, USD mn 68

Figure 41. Breakdown of European Biosurgery Market by Country, 2020 and 2027, % of Revenue 70

Figure 42. Contribution to Europe 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 71

Figure 43. Biosurgery Market in UK, 2017-2027, USD mn 72

Figure 44. Biosurgery Market in France, 2017-2027, USD mn 74

Figure 45. Biosurgery Market in Germany, 2017-2027, USD mn 76

Figure 46. Biosurgery Market in Spain, 2017-2027, USD mn 78

Figure 47. Biosurgery Market in Italy, 2017-2027, USD mn 80

Figure 48. Biosurgery Market in Russia, 2017-2027, USD mn 82

Figure 49. Biosurgery Market in Rest of Europe, 2017-2027, USD mn 84

Figure 50. Growth Stage of Europe Biosurgery Industry over the Forecast Period 86


List Of Table

Table 1. Snapshot of Europe Biosurgery Market in Balanced Perspective, 2020-2027 17

Table 2. Growth Rate of World GDP, 2020-2022 20

Table 3. Main Product Trends and Market Opportunities in Europe Biosurgery Market 30

Table 4. Europe Biosurgery Market by Product, 2017-2027, USD mn 38

Table 5. Europe Biosurgery Market: Bone-Graft Substitutes by Type, 2017-2027, USD mn 41

Table 6. Europe Biosurgery Market: Surgical Sealants and Adhesives by Type, 2017-2027, USD mn 46

Table 7. Europe Biosurgery Market: Soft-tissue Attachments by Type, 2017-2027, USD mn 49

Table 8. Europe Biosurgery Market: Adhesion Barriers by Type, 2017-2027, USD mn 52

Table 9. Europe Biosurgery Market by Source Type, 2017-2027, USD mn 56

Table 10. Europe Biosurgery Market by Application, 2017-2027, USD mn 61

Table 11. Europe Biosurgery Market by Country, 2017-2027, USD mn 71

Table 12. UK Biosurgery Market by Product, 2017-2027, USD mn 73

Table 13. UK Biosurgery Market by Source Type, 2017-2027, USD mn 73

Table 14. UK Biosurgery Market by Application, 2017-2027, USD mn 73

Table 15. France Biosurgery Market by Product, 2017-2027, USD mn 75

Table 16. France Biosurgery Market by Source Type, 2017-2027, USD mn 75

Table 17. France Biosurgery Market by Application, 2017-2027, USD mn 75

Table 18. Germany Biosurgery Market by Product, 2017-2027, USD mn 77

Table 19. Germany Biosurgery Market by Source Type, 2017-2027, USD mn 77

Table 20. Germany Biosurgery Market by Application, 2017-2027, USD mn 77

Table 21. Spain Biosurgery Market by Product, 2017-2027, USD mn 79

Table 22. Spain Biosurgery Market by Source Type, 2017-2027, USD mn 79

Table 23. Spain Biosurgery Market by Application, 2017-2027, USD mn 79

Table 24. Italy Biosurgery Market by Product, 2017-2027, USD mn 81

Table 25. Italy Biosurgery Market by Source Type, 2017-2027, USD mn 81

Table 26. Italy Biosurgery Market by Application, 2017-2027, USD mn 81

Table 27. Russia Biosurgery Market by Product, 2017-2027, USD mn 83

Table 28. Russia Biosurgery Market by Source Type, 2017-2027, USD mn 83

Table 29. Russia Biosurgery Market by Application, 2017-2027, USD mn 83

Table 30. Biosurgery Market in Rest of Europe by Country, 2017-2027, USD mn 85

Table 31. B. Braun Melsungen AG: Company Snapshot 90

Table 32. B. Braun Melsungen AG: Business Segmentation 90

Table 33. B. Braun Melsungen AG: Product Portfolio 91

Table 34. B. Braun Melsungen AG: Revenue, 2017-2019, USD mn 91

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

B. Braun Melsungen AG

Baxter International, Inc.

Becton, Dickinson and Company (C.R. Bard)

Betatech Medical

CryoLife Inc.

CSL Limited

Hemostasis LLC

Integra Lifesciences Holdings Corporation

Johnson & Johnson

Medtronic PLC

Pfizer, Inc.

Sanofi S.A.

Stryker Corporation

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)